Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
5.79
+0.08 (1.40%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Aura Biosciences Market Cap
Aura Biosciences has a market cap or net worth of $289.30 million as of April 24, 2025. Its market cap has decreased by -19.51% in one year.
Market Cap
289.30M
Enterprise Value
156.97M
1-Year Change
-19.51%
Ranking
Category
Stock Price
$5.79
Market Cap Chart
Since the IPO on October 29, 2021, Aura Biosciences's market cap has decreased from $397.73M to $289.30M, a decrease of -27.26%. That is a compound annual growth rate of -8.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 289.30M | -29.54% |
| Dec 31, 2024 | 410.60M | -5.92% |
| Dec 29, 2023 | 436.44M | 12.22% |
| Dec 30, 2022 | 388.92M | -21.59% |
| Dec 31, 2021 | 496.00M | 24.71% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 743.12B |
| UnitedHealth Group | 388.83B |
| Johnson & Johnson | 380.15B |
| AbbVie | 307.25B |
| Novo Nordisk | 266.18B |
| Abbott Laboratories | 228.46B |
| Novartis AG | 211.63B |
| AstraZeneca | 210.34B |